OsteoCure Therapeutics, Inc

Accelerating Bone Repair While Reducing Pain

Headquarters
Warsaw, Indiana
Employees
1–10
Business Model
B2B

About

OsteoCure Therapeutics is a Duke University spinout and JLABS company developing a multifunctional injectable adenosine-based platform to accelerate bone repair while reducing pain. Its lead product OCTA1 targets a $25B market spanning fracture healing, osteoporosis reversal, and bone pain management.

Summary

OsteoCure Therapeutics, Inc is a Medtech company based in Warsaw, United States.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Similar Companies